American Healthcare REIT stock price target raised to $45 by RBC Capital

Published 13/08/2025, 15:42
American Healthcare REIT stock price target raised to $45 by RBC Capital

Investing.com - RBC Capital raised its price target on American Healthcare REIT, Inc (NYSE:AHR) to $45.00 from $39.00 on Wednesday, while maintaining an Outperform rating on the stock. The company’s shares, currently trading at $40.27, have delivered an impressive 137% return over the past year, with analysts maintaining a strong buy consensus.

The price target increase follows American Healthcare REIT’s second-quarter 2025 earnings report, which RBC Capital described as showing "solid results" for the healthcare real estate investment trust.

RBC Capital highlighted a stronger organic growth outlook for the company, primarily driven by its Trilogy segment, as a key factor behind the revised target.

The firm also noted a "better investment pace" demonstrated by American Healthcare REIT in its latest quarterly performance.

RBC Capital ranks American Healthcare REIT’s growth outlook "among best in healthcare sector," according to its analysis of the company’s recent financial performance.

In other recent news, American Healthcare REIT reported its financial results for the second quarter of 2025, highlighting a strong performance. The company posted Core Funds From Operations (FFO) of $0.42 per share, surpassing both JMP Securities’ expectation of $0.39 and the consensus estimate of $0.40 per share. This earnings beat was largely due to higher net operating income from the company’s RIDEA assets. Additionally, American Healthcare REIT saw a significant 27% increase in normalized funds from operations per share. The company also raised its full-year 2025 NFFO guidance, reflecting a positive outlook. Following these developments, JMP Securities raised its price target for the company to $45.00 from $40.00 while maintaining a Market Outperform rating. These recent updates indicate a period of growth and positive investor sentiment for American Healthcare REIT.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.